https://blog.biomolbiomed.com/ The official blog of Biomolecules & Biomedicine — research highlights, peer-reviewed insights, and science in plain words. en Thu, 22 Oct 2026 13:14:35 GMT https://blog.biomolbiomed.com/article/university-of-cologne-open-access-agreement-2027 https://blog.biomolbiomed.com/article/university-of-cologne-open-access-agreement-2027 Mon, 19 Oct 2026 11:00:00 GMT noreply@biomolbiomed.com (Lamija Mlaćo) Biomolecules and Biomedicine has signed an institutional agreement with the University of Cologne and University Hospital Cologne, providing additional publishing support for their researchers from January 2027. https://blog.biomolbiomed.com/article/mostar-school-of-medicine-open-access-support https://blog.biomolbiomed.com/article/mostar-school-of-medicine-open-access-support Sat, 17 Oct 2026 18:44:00 GMT noreply@biomolbiomed.com (Lamija Mlaćo) The School of Medicine, University of Mostar has joined the Biomolecules and Biomedicine Institutional Open Access Program, supporting its researchers in publishing open access with an international audience. https://blog.biomolbiomed.com/article/sarajevo-pharmacy-open-access-publishing-support https://blog.biomolbiomed.com/article/sarajevo-pharmacy-open-access-publishing-support Thu, 17 Sep 2026 17:53:00 GMT noreply@biomolbiomed.com (Lamija Mlaćo) The University of Sarajevo – Faculty of Pharmacy has joined the Biomolecules and Biomedicine Institutional Open Access Program, providing additional open access publishing support for eligible affiliated researchers. https://blog.biomolbiomed.com/article/contrast-free-pcasl-mri-radiomics-chronic-kidney-disease https://blog.biomolbiomed.com/article/contrast-free-pcasl-mri-radiomics-chronic-kidney-disease Wed, 16 Sep 2026 17:51:40 GMT noreply@biomolbiomed.com (Lamija Mlaćo) A multicenter study of 405 participants shows that contrast-free pCASL MRI of renal blood flow, combined with radiomics and clinical data, can support early diagnosis and staging of chronic kidney disease. https://blog.biomolbiomed.com/article/the-reviewer-of-the-month-for-september-2026-liliana-luca https://blog.biomolbiomed.com/article/the-reviewer-of-the-month-for-september-2026-liliana-luca Mon, 07 Sep 2026 12:00:00 GMT noreply@biomolbiomed.com (Lamija Mlaćo) Biomolecules and Biomedicine recognizes Liliana Luca, lecturer at Ștefan cel Mare University of Suceava and specialist medical biologist, as Reviewer of the Month for September 2026. https://blog.biomolbiomed.com/article/hantaviruses-southeastern-europe-epidemiology-ecological-drivers-one-health https://blog.biomolbiomed.com/article/hantaviruses-southeastern-europe-epidemiology-ecological-drivers-one-health Tue, 01 Sep 2026 18:20:24 GMT noreply@biomolbiomed.com (Lamija Mlaćo) Two new papers in Biomolecules and Biomedicine show that hantavirus disease in Southeastern Europe is not a set of isolated national problems, but one regional ecological and epidemiological phenomenon that demands a One Health response. https://blog.biomolbiomed.com/article/cio-symposium-exercise-immunotherapy-chronic-fatigue-2026 https://blog.biomolbiomed.com/article/cio-symposium-exercise-immunotherapy-chronic-fatigue-2026 Mon, 31 Aug 2026 10:00:00 GMT noreply@biomolbiomed.com (Faruk Skenderi) A free virtual symposium organized by the Center for Integrated Oncology (CIO) Aachen Bonn Cologne Duesseldorf will explore how exercise can help manage immunotherapy-related chronic fatigue in cancer patients, on 6 November 2026, with international keynote speakers and flash poster presentations. https://blog.biomolbiomed.com/article/silymarin-type-2-diabetes-nasr-eddine-kebir https://blog.biomolbiomed.com/article/silymarin-type-2-diabetes-nasr-eddine-kebir Sun, 30 Aug 2026 00:00:00 GMT noreply@biomolbiomed.com (Lamija Mlaćo) Dr. Nasr-Eddine Kebir explains why silymarin is scientifically promising in type 2 diabetes, why it is not yet an established treatment, and what future clinical trials must address. https://blog.biomolbiomed.com/article/the-reviewer-of-the-month-for-august-2026-dr-ioannis-kyriakidis https://blog.biomolbiomed.com/article/the-reviewer-of-the-month-for-august-2026-dr-ioannis-kyriakidis Mon, 24 Aug 2026 12:00:00 GMT noreply@biomolbiomed.com (Lamija Mlaćo) Biomolecules and Biomedicine recognizes Dr. Ioannis Kyriakidis, pediatric hematologist-oncologist at the University Hospital of Heraklion and postdoctoral researcher at the University of Crete, as the Reviewer of the Month for August 2026. https://blog.biomolbiomed.com/article/prp-assisted-nonoperative-acl-treatment-shinnosuke-hada https://blog.biomolbiomed.com/article/prp-assisted-nonoperative-acl-treatment-shinnosuke-hada Mon, 17 Aug 2026 00:00:00 GMT noreply@biomolbiomed.com (Lamija Mlaćo) Dr. Shinnosuke Hada explains how one athlete's recovery inspired research into PRP-assisted nonoperative ACL treatment and why individualized patient selection matters. https://blog.biomolbiomed.com/article/dietary-polyphenols-colorectal-cancer-haifa-alqahtani https://blog.biomolbiomed.com/article/dietary-polyphenols-colorectal-cancer-haifa-alqahtani Sun, 16 Aug 2026 00:00:00 GMT noreply@biomolbiomed.com (Lamija Mlaćo) Dr. Haifa A. Alqahtani discusses the promise and current limitations of curcumin, resveratrol, and EGCG in colorectal cancer, from laboratory evidence to future clinical trials. https://blog.biomolbiomed.com/article/the-reviewer-of-the-month-for-july-2026-dr-chao-han-lai https://blog.biomolbiomed.com/article/the-reviewer-of-the-month-for-july-2026-dr-chao-han-lai Fri, 31 Jul 2026 12:00:00 GMT noreply@biomolbiomed.com (Lamija Mlaćo) Biomolecules and Biomedicine recognizes Dr. Chao-Han Lai, Distinguished Professor of Surgery at National Cheng Kung University College of Medicine, as the Reviewer of the Month for July 2026. https://blog.biomolbiomed.com/article/the-reviewer-of-the-month-for-june-2026-jiranuwat-sapudom https://blog.biomolbiomed.com/article/the-reviewer-of-the-month-for-june-2026-jiranuwat-sapudom Mon, 27 Jul 2026 12:00:00 GMT noreply@biomolbiomed.com (Lamija Mlaćo) Biomolecules and Biomedicine recognizes Jiranuwat Sapudom, Research Scientist at New York University Abu Dhabi, as the Reviewer of the Month for June 2026. https://blog.biomolbiomed.com/article/the-reviewer-of-the-month-for-may-2026-dr-jeffrey-c-buchsbaum https://blog.biomolbiomed.com/article/the-reviewer-of-the-month-for-may-2026-dr-jeffrey-c-buchsbaum Mon, 22 Jun 2026 12:00:00 GMT noreply@biomolbiomed.com (Lamija Mlaćo) Biomolecules and Biomedicine recognizes Dr. Jeffrey C. Buchsbaum, Medical Officer at the National Cancer Institute, as the Reviewer of the Month for May 2026. https://blog.biomolbiomed.com/article/biomolecules-biomedicine-2025-journal-impact-factor-2-8 https://blog.biomolbiomed.com/article/biomolecules-biomedicine-2025-journal-impact-factor-2-8 Sun, 21 Jun 2026 12:00:00 GMT noreply@biomolbiomed.com (Lamija Mlaćo) Biomolecules and Biomedicine's 2025 Journal Impact Factor is 2.8 (JCR™). See its 5-year IF, Q3 rank (103/191) and other key 2025 citation metrics. https://blog.biomolbiomed.com/article/sepsis-survival-prediction-apache-ii-sofa-charlson-comorbidity-index https://blog.biomolbiomed.com/article/sepsis-survival-prediction-apache-ii-sofa-charlson-comorbidity-index Tue, 02 Jun 2026 12:00:00 GMT noreply@biomolbiomed.com (Lamija Mlaćo) Gavrilovic et al. compare APACHE II, SOFA, and the Charlson Comorbidity Index for predicting 28-day mortality in 392 sepsis patients in a Serbian ICU, finding that acute illness scores outperform comorbidity-based scoring in septic shock. https://blog.biomolbiomed.com/article/the-reviewer-of-the-month-for-april-2026-dr-alice-vassiliou https://blog.biomolbiomed.com/article/the-reviewer-of-the-month-for-april-2026-dr-alice-vassiliou Thu, 21 May 2026 12:00:00 GMT noreply@biomolbiomed.com (Lamija Mlaćo) Biomolecules and Biomedicine recognizes Dr. Alice Vassiliou, Assistant Professor of Biochemistry–Molecular Pulmonology at NKUA, as the Reviewer of the Month for April 2026. https://blog.biomolbiomed.com/article/the-reviewer-of-the-month-for-march-2026-thiago-luis-scudeler-md-phd https://blog.biomolbiomed.com/article/the-reviewer-of-the-month-for-march-2026-thiago-luis-scudeler-md-phd Sat, 02 May 2026 12:00:00 GMT noreply@biomolbiomed.com (Lamija Mlaćo) Biomolecules and Biomedicine is pleased to recognize Thiago Luis Scudeler, MD, PhD, attending physician and researcher at the Heart Institute (InCor), University of São Paulo, as our Reviewer of the Month for March 2026. https://blog.biomolbiomed.com/article/the-reviewer-of-the-month-for-february-2026-radka-michalkova-phd https://blog.biomolbiomed.com/article/the-reviewer-of-the-month-for-february-2026-radka-michalkova-phd Mon, 20 Apr 2026 12:00:00 GMT noreply@biomolbiomed.com (Lamija Mlaćo) Biomolecules and Biomedicine is proud to recognize Dr. Radka Michalková, PhD, of Pavol Jozef Šafárik University in Košice, Slovakia, as our Reviewer of the Month for February 2026. https://blog.biomolbiomed.com/article/interview-most-cited-paper-award-2026-sars-cov-2-multi-organ-damage https://blog.biomolbiomed.com/article/interview-most-cited-paper-award-2026-sars-cov-2-multi-organ-damage Sun, 15 Mar 2026 00:00:00 GMT noreply@biomolbiomed.com (Lamija Mlaćo) The Most Cited Paper Award 2026 recognizes the most cited article published in Biomolecules and Biomedicine in 2023. We spoke with the author team behind the winning review on SARS‑CoV‑2 and multi‑organ injury about what motivated the work, the key mechanisms, and what research questions remain most urgent. https://blog.biomolbiomed.com/article/welcoming-prof-nicolai-j-wewer-albrechtsen-as-co-editor-in-chief https://blog.biomolbiomed.com/article/welcoming-prof-nicolai-j-wewer-albrechtsen-as-co-editor-in-chief Wed, 04 Mar 2026 12:00:00 GMT noreply@biomolbiomed.com (Lamija Mlaco, MD) Prof. Nicolai J. Wewer Albrechtsen, MD, PhD joins Biomolecules and Biomedicine as Co‑Editor‑in‑Chief from March 2026. Read his short Q&A on rigor, peer review, and clinically meaningful molecular research. https://blog.biomolbiomed.com/article/18th-bryan-warren-school-of-pathology-bwsp-2026 https://blog.biomolbiomed.com/article/18th-bryan-warren-school-of-pathology-bwsp-2026 Tue, 03 Mar 2026 12:00:00 GMT noreply@biomolbiomed.com (Faruk Skenderi) The 18th Bryan Warren School of Pathology (BWSP 2026) will take place on June 27–28, 2026, in Sarajevo, Bosnia and Herzegovina, and online. This hybrid gastrointestinal pathology workshop offers 9.5 EACCME® credits and features world-renowned faculty. https://blog.biomolbiomed.com/article/11th-national-congress-of-cytopathology-2026 https://blog.biomolbiomed.com/article/11th-national-congress-of-cytopathology-2026 Wed, 25 Feb 2026 12:00:00 GMT noreply@biomolbiomed.com (Faruk Skenderi) The 11th National Congress of Cytopathology with International Participation will be held at the Hilton İstanbul Bakırköy from April 3 to 5, 2026, under the theme "Evolving Cytopathology: Where Morphology Meets Molecular Techniques, Digitalization and Artificial Intelligence." https://blog.biomolbiomed.com/article/most-cited-paper-award-2026 https://blog.biomolbiomed.com/article/most-cited-paper-award-2026 Sat, 21 Feb 2026 21:51:29 GMT noreply@biomolbiomed.com (Lamija Mlaćo) Biomolecules and Biomedicine is pleased to announce the recipient of the Most Cited Paper Award 2026, as well as the remaining papers in our Top 5 Most Cited list, according to Dimensions […] https://blog.biomolbiomed.com/article/the-reviewer-of-the-month-for-january-2026-aleksandar-mijovic-mbbs-phd-frcpath https://blog.biomolbiomed.com/article/the-reviewer-of-the-month-for-january-2026-aleksandar-mijovic-mbbs-phd-frcpath Sat, 14 Feb 2026 13:15:42 GMT noreply@biomolbiomed.com (Lamija Mlaćo) Peer review is a cornerstone of academic publishing. It strengthens scientific manuscripts, improves clarity and methodology, and […] https://blog.biomolbiomed.com/article/thank-you-to-our-2025-reviewers https://blog.biomolbiomed.com/article/thank-you-to-our-2025-reviewers Wed, 11 Feb 2026 14:57:56 GMT noreply@biomolbiomed.com (Lamija Mlaćo) Peer review is at the heart of scholarly publishing, and Biomolecules and Biomedicine would not be able to maintain the quality, rigor, and integrity of its content without the dedication of our expert […] https://blog.biomolbiomed.com/article/10th-bosnian-turkish-school-of-cytopathology-2026 https://blog.biomolbiomed.com/article/10th-bosnian-turkish-school-of-cytopathology-2026 Thu, 05 Feb 2026 12:00:00 GMT noreply@biomolbiomed.com (Faruk Skenderi) The 10th Bosnian Turkish School of Cytopathology (BTCS 2026) will be held online on June 10, 2026, focusing on exfoliative cytopathology with 8 expert faculty members. https://blog.biomolbiomed.com/article/induced-sputum-kl-6-and-hrct-scoring-in-idiopathic-pulmonary-fibrosis https://blog.biomolbiomed.com/article/induced-sputum-kl-6-and-hrct-scoring-in-idiopathic-pulmonary-fibrosis Mon, 29 Dec 2025 13:53:31 GMT noreply@biomolbiomed.com (Lamija Mlaćo) Background and Study Objective Zhang and colleagues investigated whether KL-6 measured in induced sputum can help with the diagnosis and assessment of idiopathic pulmonary fibrosis (IPF). Specifically, the study asked two linked questions: Can induced […] https://blog.biomolbiomed.com/article/prof-luca-testarelli-bridging-restorative-dentistry-endodontics-and-digital-innovation https://blog.biomolbiomed.com/article/prof-luca-testarelli-bridging-restorative-dentistry-endodontics-and-digital-innovation Fri, 26 Dec 2025 14:19:56 GMT noreply@biomolbiomed.com (Lamija Mlaćo) Prof. Luca Testarelli is a Full Professor at Sapienza University of Rome (Department of Odontostomatological and Maxillo-Facial Sciences). His work connects clinical dentistry and research, with a main focus on endodontics and restorative dentistry. He […] https://blog.biomolbiomed.com/article/shr-and-siri-improve-chd-detection-in-type-2-diabetes https://blog.biomolbiomed.com/article/shr-and-siri-improve-chd-detection-in-type-2-diabetes Fri, 26 Dec 2025 11:54:44 GMT noreply@biomolbiomed.com (Lamija Mlaćo) A retrospective angiography study in T2DM suggests that pairing a stress-glycemia index (SHR) with an inflammation index (SIRI) improves CHD risk stratification compared with using either marker alone. Why CHD is a high-stakes problem in […] https://blog.biomolbiomed.com/article/irf5-variants-linked-to-rheumatoid-arthritis-risk-in-mexican-women https://blog.biomolbiomed.com/article/irf5-variants-linked-to-rheumatoid-arthritis-risk-in-mexican-women Wed, 24 Dec 2025 12:53:05 GMT noreply@biomolbiomed.com (Lamija Mlaćo) Disease Background and Immunopathology Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disease that affects ~0.5%–1% of adults worldwide. It occurs more often in women than men, with reported female-to-male ratios of 4:1 in younger […] https://blog.biomolbiomed.com/article/small-cell-lung-cancer-sclc-at-the-door-of-targeted-therapies https://blog.biomolbiomed.com/article/small-cell-lung-cancer-sclc-at-the-door-of-targeted-therapies Mon, 22 Dec 2025 11:14:59 GMT noreply@biomolbiomed.com (Lamija Mlaćo) Small cell lung cancer (SCLC) is a neuroendocrine lung cancer strongly linked to tobacco exposure. It accounts for about 15% of lung cancers, with roughly 150,000 new diagnoses worldwide each year. For decades, it has […] https://blog.biomolbiomed.com/article/topical-nitroglycerin-improves-skin-flap-survival-by-boosting-blood-vessel-growth https://blog.biomolbiomed.com/article/topical-nitroglycerin-improves-skin-flap-survival-by-boosting-blood-vessel-growth Fri, 19 Dec 2025 12:16:48 GMT noreply@biomolbiomed.com (Lamija Mlaćo) Clinical context: flap autonomization and ischemic risk In reconstructive surgery, skin flaps are used to transfer tissue while maintaining a blood supply through a vascular pedicle. A persistent challenge is distal flap ischemia and partial […] https://blog.biomolbiomed.com/article/tubb-clta-and-fbxl5-as-blood-markers-for-postmenopausal-osteoporosis https://blog.biomolbiomed.com/article/tubb-clta-and-fbxl5-as-blood-markers-for-postmenopausal-osteoporosis Wed, 17 Dec 2025 10:53:23 GMT noreply@biomolbiomed.com (Lamija Mlaćo) Understanding postmenopausal osteoporosis Postmenopausal osteoporosis is a common bone disorder that affects women after menopause and is characterized by reduced bone mass and increased fracture risk. The condition is closely linked to hormonal changes, particularly […] https://blog.biomolbiomed.com/article/extraovarian-fibrothecoma-a-benign-tumor-that-can-mimic-ovarian-cancer https://blog.biomolbiomed.com/article/extraovarian-fibrothecoma-a-benign-tumor-that-can-mimic-ovarian-cancer Mon, 15 Dec 2025 12:35:37 GMT noreply@biomolbiomed.com (Lamija Mlaćo) Extraovarian fibroma–thecoma tumors in context Fibromas and thecomas belong to the sex cord–stromal tumor group and are usually benign and ovarian in origin. Fibromas represent about 4% of ovarian tumors, while thecomas account for roughly […] https://blog.biomolbiomed.com/article/how-tumors-rewire-glucose-metabolism-to-escape-copper-induced-cell-death https://blog.biomolbiomed.com/article/how-tumors-rewire-glucose-metabolism-to-escape-copper-induced-cell-death Fri, 12 Dec 2025 10:51:47 GMT noreply@biomolbiomed.com (Lamija Mlaćo) Understanding the Link Between Cancer Metabolism and Cuproptosis Cancer cells have a remarkable ability to survive under stress. One of their key survival tricks is metabolic reprogramming—shifting how they use nutrients like glucose to support […] https://blog.biomolbiomed.com/article/presepsin-shows-strong-potential-for-improving-sepsis-diagnosis https://blog.biomolbiomed.com/article/presepsin-shows-strong-potential-for-improving-sepsis-diagnosis Wed, 10 Dec 2025 17:08:26 GMT noreply@biomolbiomed.com (Lamija Mlaćo) Sepsis remains one of the most serious medical emergencies. It develops when the body responds to an infection in a way that injures its own organs. Patients can deteriorate quickly, and delays in treatment raise […] https://blog.biomolbiomed.com/article/the-reviewer-of-the-month-for-december-2025-marko-bojovic-md https://blog.biomolbiomed.com/article/the-reviewer-of-the-month-for-december-2025-marko-bojovic-md Wed, 10 Dec 2025 11:19:57 GMT noreply@biomolbiomed.com (Lamija Mlaćo) Peer Review in Academic Publishing: Honoring Outstanding Scientific Contribution Peer review plays a fundamental role in academic publishing by ensuring the accuracy, credibility, and ethical conduct of scientific research. To acknowledge the essential work of […] https://blog.biomolbiomed.com/article/sugammadex-vs-neostigmine-new-evidence-on-post-anesthesia-recovery https://blog.biomolbiomed.com/article/sugammadex-vs-neostigmine-new-evidence-on-post-anesthesia-recovery Mon, 08 Dec 2025 11:05:16 GMT noreply@biomolbiomed.com (Lamija Mlaćo) Why Reversal Drugs Matter After Anesthesia General anesthesia is used in hundreds of millions of surgeries each year, and neuromuscular blocking agents (NMBAs) are essential for safe intubation and good surgical conditions. When the effects […] https://blog.biomolbiomed.com/article/how-gut-microbial-metabolites-impact-alzheimers-disease-insights-into-the-brain-gut-axis https://blog.biomolbiomed.com/article/how-gut-microbial-metabolites-impact-alzheimers-disease-insights-into-the-brain-gut-axis Fri, 05 Dec 2025 12:44:35 GMT noreply@biomolbiomed.com (Lamija Mlaćo) Alzheimer’s disease (AD) is a progressive neurodegenerative disorder primarily marked by cognitive decline and memory loss. As one of the leading causes of dementia worldwide, AD affects millions and places a growing burden on healthcare […] https://blog.biomolbiomed.com/article/thymoquinone-3hq-combo-targets-esbl-antibiotic-resistance https://blog.biomolbiomed.com/article/thymoquinone-3hq-combo-targets-esbl-antibiotic-resistance Wed, 03 Dec 2025 12:30:34 GMT noreply@biomolbiomed.com (Lamija Mlaćo) Researchers report the first evidence that two existing compounds work together to hit hard-to-treat ESBL-producing bacteria and the CTX-M-15 enzyme. Why ESBL-producing bacteria are so difficult to treat Bacterial infections remain a major cause of […] https://blog.biomolbiomed.com/article/iv-iron-therapy-in-hemodialysis-does-it-impact-mortality-and-heart-risks https://blog.biomolbiomed.com/article/iv-iron-therapy-in-hemodialysis-does-it-impact-mortality-and-heart-risks Mon, 01 Dec 2025 10:57:41 GMT noreply@biomolbiomed.com (Lamija Mlaćo) Introduction: The Challenge of Iron Deficiency in Hemodialysis Patients Iron deficiency is a common issue for patients undergoing hemodialysis, a life-saving treatment for those with end-stage renal disease (ESRD). Chronic kidney disease (CKD) affects millions […] https://blog.biomolbiomed.com/article/neuropeptide-s-pathway-a-key-target-in-ptsd-and-neuropsychiatric-disorders https://blog.biomolbiomed.com/article/neuropeptide-s-pathway-a-key-target-in-ptsd-and-neuropsychiatric-disorders Thu, 27 Nov 2025 11:14:38 GMT noreply@biomolbiomed.com (Lamija Mlaćo) Introduction: What is PTSD? Post-Traumatic Stress Disorder (PTSD) is a mental health condition that can develop after an individual experiences or witnesses a life-threatening event. Unlike normal stress reactions, PTSD involves prolonged, severe symptoms that […] https://blog.biomolbiomed.com/article/passenger-lymphocyte-syndrome-updated-insights-into-an-overlooked-transplant-complication https://blog.biomolbiomed.com/article/passenger-lymphocyte-syndrome-updated-insights-into-an-overlooked-transplant-complication Mon, 24 Nov 2025 13:10:35 GMT noreply@biomolbiomed.com (Lamija Mlaćo) Passenger lymphocyte syndrome (PLS) is becoming increasingly relevant as transplant centers expand the use of ABO-incompatible procedures to address persistent organ shortages. Although first described decades ago, PLS continues to challenge clinicians due to its […] https://blog.biomolbiomed.com/article/reviewing-systematic-reviews-and-meta-analyses-a-practical-guide https://blog.biomolbiomed.com/article/reviewing-systematic-reviews-and-meta-analyses-a-practical-guide Fri, 21 Nov 2025 10:53:57 GMT noreply@biomolbiomed.com (Lamija Mlaćo) How Peer Reviewers Can Protect Systematic Reviews and Meta-Analyses Systematic reviews and meta-analyses sit at the top of evidence hierarchies. As Emir Begagić and colleagues write, they “represent the highest tier of evidence in the […] https://blog.biomolbiomed.com/article/atherogenic-index-of-plasma-and-kidney-risk-in-type-2-diabetes https://blog.biomolbiomed.com/article/atherogenic-index-of-plasma-and-kidney-risk-in-type-2-diabetes Wed, 19 Nov 2025 11:01:04 GMT noreply@biomolbiomed.com (Lamija Mlaćo) Diabetic Kidney Damage Diabetic nephropathy is one of the most serious long-term complications of type 2 diabetes mellitus (TTDM). It is characterized by persistent albumin in the urine, a declining filtration capacity of the kidneys, […] https://blog.biomolbiomed.com/article/first-trimester-prediction-of-early-onset-preeclampsia-using-papp-a-and-map https://blog.biomolbiomed.com/article/first-trimester-prediction-of-early-onset-preeclampsia-using-papp-a-and-map Mon, 17 Nov 2025 10:49:01 GMT noreply@biomolbiomed.com (Lamija Mlaćo) Preeclampsia (PE) is a serious pregnancy complication that affects both the mother and fetus, often leading to severe health issues, including premature birth, low birth weight, and maternal organ failure. The condition is characterized by […] https://blog.biomolbiomed.com/article/serum-nptx2-and-cognitive-impairment-in-geriatric-diabetes https://blog.biomolbiomed.com/article/serum-nptx2-and-cognitive-impairment-in-geriatric-diabetes Fri, 14 Nov 2025 09:39:42 GMT noreply@biomolbiomed.com (Lamija Mlaćo) Understanding Diabetes and Cognitive Impairment Diabetes mellitus is a long-term metabolic disease marked by persistent high blood sugar. Over time, it leads to serious complications involving both small and large blood vessels. As treatments have […] https://blog.biomolbiomed.com/article/neuroprotective-effects-of-melatonin-and-omega-3-against-prenatal-electromagnetic-field-exposure https://blog.biomolbiomed.com/article/neuroprotective-effects-of-melatonin-and-omega-3-against-prenatal-electromagnetic-field-exposure Wed, 12 Nov 2025 13:00:09 GMT noreply@biomolbiomed.com (Lamija Mlaćo) As technology advances, concerns about the effects of electromagnetic fields (EMFs) on human health continue to grow. A recent study by researchers at Ondokuz Mayıs University explores how prenatal exposure to 900 MHz EMF impacts […] https://blog.biomolbiomed.com/article/the-reviewer-of-the-month-for-november-2025-maja-jazvinscak-jembrek-phd https://blog.biomolbiomed.com/article/the-reviewer-of-the-month-for-november-2025-maja-jazvinscak-jembrek-phd Tue, 11 Nov 2025 15:54:05 GMT noreply@biomolbiomed.com (Lamija Mlaćo) Peer Review in Academic Publishing: Recognizing Excellence in Scientific Research Peer review is a cornerstone of academic publishing, safeguarding the integrity, reliability, and ethical quality of scientific work. In recognition of the vital contributions made […]